Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes 57:e6 2008
DOI: 10.2337/db07-1572
© 2008 by the American Diabetes Association
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thomas, D. C.
Right arrow Articles by Cooke, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thomas, D. C.
Right arrow Articles by Cooke, A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Online Letters to the Editor

Comment on: Tritt et al. (2007) Functional Waning of Naturally Occurring CD4+ Regulatory T-cells Contributes to the Onset of Autoimmune Diabetes: Diabetes 57:113–123, 2007

David C. Thomas1, Richard J. Mellanby2, and Anne Cooke3

1 Cambridge Institute For Medical Research, Addenbrooke’s Hospital, Cambridge, U.K
2 Division of Veterinary Clinical Studies, Royal School of Veterinary Studies, University of Edinburgh, Midlothian, U.K
3 Department of Pathology, University of Cambridge, Cambridge, U.K

Address correspondence and reprint requests to Dr. David C. Thomas, Cambridge Institute for Medical Research, Wellcome Trust/MRC Building, Addenbrooke’s Hospital, Hills Road, Cambridge, CB2 0XY, U.K. E-mail: tdct2{at}cam.ac.uk

We read with interest the recent study by Tritt et al. (1), which examined the Foxp3+ regulatory T-cells (Tregs) of NOD and BDC2.5NOD mice. The authors found that Tregs from 6- to 8-week-old BDC2.5NOD mice, but not those from 3- to 4-week-old mice, were unable to suppress diabetes in an in vivo transfer model. We feel, however, that a wealth of evidence has underlined the crucial importance of these cells in BDC2.5NOD mice throughout life and that any defects in Treg function in BDC2.5NOD mice are likely to be very subtle.

First, it is surprising that defects in BDC2.5NOD Treg function are apparent so early in life. In NOD mice, which have a much higher incidence of diabetes and a less autoreactive repertoire, Treg defects were not noted until much later (2). Because of its highly autoreactive repertoire, the BDC2.5NOD mouse is heavily dependent on Foxp3+ Tregs to remain tolerant. Crossing to a Foxp3null background results in highly accelerated disease (3). Also, immunoregulation by interleukin-10 remains important as BDC2.5NOD mice age beyond 6 weeks (4). Our recent work has shown robust suppressive capabilities of Tregs from both young (age 4 weeks) and old (age 20 weeks) BDC2.5NOD mice (5), though we have not examined the low Treg–to–effector T-cell ratios used in the study by Tritt et al. in vivo. Furthermore, we found an age-related increase in the number and frequency of Tregs in BDC2.5NOD mice. Thus, we feel that defects in Treg function in BDC2.5NOD mice are likely to be minor given their low incidence of diabetes, the mouse’s heavy dependence on the presence of Tregs, and the functionality of Tregs in even very old mice. In addition, the reported defects may be offset by the dramatic age-related rise in Treg frequency in a variety of organs.

Definitive answers on subtle changes in Treg function in the NOD strain are likely to be provided by the use of NOD mice that express green fluorescent protein under the Foxp3 promoter. This will not only allow high purity isolation of Tregs that are uncontaminated by activated CD25low cells but will also include the significant number of Tregs that are Foxp3+CD25.

Received for publication November 6, 2007 and accepted in revised form November 9, 2007


    REFERENCES
 TOP
 REFERENCES
 

  1. Tritt M, Sgouroudis E, d’Hennezel E, Albanese A, Piccirillo CA: Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes. Diabetes 57:113–123, 2007[Medline]
  2. Gregori S, Giarratana N, Smiroldo S, Adorini L: Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development. J Immunol 171:4040–4047, 2003[Abstract/Free Full Text]
  3. Chen Z, Herman AE, Matos M, Mathis D, Benoist C: Where CD4+CD25+ T reg cells impinge on autoimmune diabetes. J Exp Med 202:1387–1397, 2005[Abstract/Free Full Text]
  4. Phillips JM, Parish NM, Drage M, Cooke A: Cutting edge: interactions through the IL-10 receptor regulate autoimmune diabetes. J Immunol 167:6087–6091, 2001[Abstract/Free Full Text]
  5. Thomas DC, Mellanby RJ, Phillips JM, Cooke A: An early age-related increase in the frequency of CD4+ Foxp3+ cells in BDC2.5NOD mice. Immunology 121:565–576, Aug 2007[Medline]

Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
M. Tritt, E. Sgouroudis, E. d'Hennezel, A. Albanese, and C. A. Piccirillo
Response to Comment on: Tritt et al. (2007) Functional Waning of Naturally Occurring CD4+ Regulatory T-Cells Contributes to the Onset of Autoimmune Diabetes: Diabetes 57:113-123, 2007
Diabetes, March 1, 2008; 57(3): e7 - e8.
[Full Text] [PDF]


This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thomas, D. C.
Right arrow Articles by Cooke, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thomas, D. C.
Right arrow Articles by Cooke, A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum